Cargando…
Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440619/ https://www.ncbi.nlm.nih.gov/pubmed/34521806 http://dx.doi.org/10.1038/s41392-021-00672-7 |
_version_ | 1783752714697572352 |
---|---|
author | Hu, Chen Zou, Fengming Wang, Aoli Miao, Weili Liang, Qianmao Weisberg, Ellen L. Wang, Yinsheng Liu, Jing Wang, Wenchao Liu, Qingsong |
author_facet | Hu, Chen Zou, Fengming Wang, Aoli Miao, Weili Liang, Qianmao Weisberg, Ellen L. Wang, Yinsheng Liu, Jing Wang, Wenchao Liu, Qingsong |
author_sort | Hu, Chen |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8440619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-84406192021-10-04 Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia Hu, Chen Zou, Fengming Wang, Aoli Miao, Weili Liang, Qianmao Weisberg, Ellen L. Wang, Yinsheng Liu, Jing Wang, Wenchao Liu, Qingsong Signal Transduct Target Ther Letter Nature Publishing Group UK 2021-09-15 /pmc/articles/PMC8440619/ /pubmed/34521806 http://dx.doi.org/10.1038/s41392-021-00672-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter Hu, Chen Zou, Fengming Wang, Aoli Miao, Weili Liang, Qianmao Weisberg, Ellen L. Wang, Yinsheng Liu, Jing Wang, Wenchao Liu, Qingsong Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia |
title | Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia |
title_full | Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia |
title_fullStr | Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia |
title_full_unstemmed | Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia |
title_short | Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia |
title_sort | targeting chaperon protein hsp70 as a novel therapeutic strategy for flt3-itd-positive acute myeloid leukemia |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440619/ https://www.ncbi.nlm.nih.gov/pubmed/34521806 http://dx.doi.org/10.1038/s41392-021-00672-7 |
work_keys_str_mv | AT huchen targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia AT zoufengming targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia AT wangaoli targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia AT miaoweili targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia AT liangqianmao targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia AT weisbergellenl targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia AT wangyinsheng targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia AT liujing targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia AT wangwenchao targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia AT liuqingsong targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia |